The materials (plastics capable of selectively recognising a substance, in this case the anaesthetic propofol) are prepared using the ”Molecular Imprinting” technique. The nano-structured plastics are the key ”intellectual property” underlying development of a biosensor now in clinical trials. The plastics are being further exploited by a Cambridge (UK) company developing other sensor platforms. The first full description of how these materials function was disclosed in a paper published this week in the highly respected Journal of Molecular Recognition.
Miruna Petcu, a Kalmar ”industrial” PhD student employed by HortReseach Ltd, successfully defended her PhD thesis in Kalmar in September. Project leader Professor Ian A. Nicholls states, ”We anticipate that the impact of these results shall be felt in the operating theatre, though patients should not feel a thing! This is a good example of how our work with advanced materials and diagnostics is being directed towards improving tomorrow’s healthcare. This also provides a good example of Kalmar’s international leadership in this field at the crossroads of biotechnology and materials engineering”.